Synthesis and Mechanism of Action
- Synthesis: Corticoliberin is produced by parvocellular secretory neurons located in the periventricular regions of the hypothalamus (hypophysiotropic area). These cells exhibit dual properties: as neurons, they generate electrical impulses, and as endocrine cells, they synthesize specific neurosecretions. Chemically, CRH is a peptide. During puberty, these structures mature, forming tight synaptic connections between neurotransmitter-secreting cells and corticoliberin-producing neurons.
- Transport: CRH reaches the pituitary gland not via axonal transport, but through a humoral pathway. It is released into the primary capillary plexus, travels through the hypophyseal portal system, and reaches the secondary capillary plexus of the adenohypophysis. The portal system facilitates bidirectional communication between the hypothalamus and the pituitary gland.
- Effect: In the anterior pituitary (adenohypophysis), CRH stimulates the synthesis and release of the tropic hormone ACTH (adrenocorticotropic hormone, or corticotropin).
Regulation of Secretion
The function of the hypothalamic-pituitary-adrenal axis relies on a cascade mechanism involving feedback loops.
- Stimulation (+): CRH production is upregulated by hypoglycemia, tissue trauma, and infection.
- Inhibition (-): Regulated via negative feedback. Elevated levels of cortisol inhibit the secretion of corticoliberin in the hypothalamus and ACTH in the pituitary. Hypothalamic dopamine also exerts an inhibitory effect on CRH secretion. A reduction in this dopaminergic tone leads to increased ACTH production.
Clinical Significance and Pathologies
- CRH Hypersecretion: Excess corticoliberin resulting from traumatic brain injury or neuroinfections affecting the hypothalamus leads to ACTH hypersecretion and bilateral adrenal cortex hyperplasia. This causes central hypercortisolism, known as Cushing's disease. Hypercortisolism induces systemic metabolic disturbances affecting protein, lipid, carbohydrate, and electrolyte metabolism: enhanced gluconeogenesis, steroid-induced diabetes mellitus, hypokalemic alkalosis, and centripetal obesity with a "moon face" and fat accumulation on the neck and upper trunk. In children, variable degrees of virilization may occur, while adults develop signs of virilization later in the disease course. In the gastrointestinal tract, excess glucocorticoids cause neurohumoral shifts: gastric hypersecretion, suppression of mucus production, and inhibition of gastric mucosal regeneration.
- CRH Deficiency: Observed in secondary (central, hypothalamic-pituitary) endocrine disorders. Hypothalamic lesions, including tumors, ischemia, hemorrhage, and congenital anomalies, lead to a deficiency in corticoliberin.
- Therapeutic Application: During suppressive glucocorticoid therapy, the negative feedback principle is utilized: CRH and ACTH secretion is suppressed, which subsequently inhibits endogenous steroidogenesis by the adrenal cortex.